Copyright Reports & Markets. All rights reserved.

Global Cholera Vaccine (Oral Route) Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Cholera Vaccine (Oral Route) Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Cholera Vaccine (Oral Route) Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Cholera Vaccine (Oral Route) Market Size Growth Rate by Type
    • 1.4.2 Shanchol
    • 1.4.3 Dukoral
    • 1.4.4 Vaxchora
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Cholera Vaccine (Oral Route) Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Research & Academic Laboratories
    • 1.5.4 Pharmaceutical & Biotechnology Companies
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Cholera Vaccine (Oral Route) Market Size, Estimates and Forecasts
    • 2.1.1 Global Cholera Vaccine (Oral Route) Revenue 2015-2026
    • 2.1.2 Global Cholera Vaccine (Oral Route) Sales 2015-2026
  • 2.2 Global Cholera Vaccine (Oral Route), Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Cholera Vaccine (Oral Route) Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Cholera Vaccine (Oral Route) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Cholera Vaccine (Oral Route) Competitor Landscape by Players

  • 3.1 Cholera Vaccine (Oral Route) Sales by Manufacturers
    • 3.1.1 Cholera Vaccine (Oral Route) Sales by Manufacturers (2015-2020)
    • 3.1.2 Cholera Vaccine (Oral Route) Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Cholera Vaccine (Oral Route) Revenue by Manufacturers
    • 3.2.1 Cholera Vaccine (Oral Route) Revenue by Manufacturers (2015-2020)
    • 3.2.2 Cholera Vaccine (Oral Route) Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Cholera Vaccine (Oral Route) Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Cholera Vaccine (Oral Route) Revenue in 2019
    • 3.2.5 Global Cholera Vaccine (Oral Route) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Cholera Vaccine (Oral Route) Price by Manufacturers
  • 3.4 Cholera Vaccine (Oral Route) Manufacturing Base Distribution, Product Types
    • 3.4.1 Cholera Vaccine (Oral Route) Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Cholera Vaccine (Oral Route) Product Type
    • 3.4.3 Date of International Manufacturers Enter into Cholera Vaccine (Oral Route) Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Cholera Vaccine (Oral Route) Market Size by Type (2015-2020)
    • 4.1.1 Global Cholera Vaccine (Oral Route) Sales by Type (2015-2020)
    • 4.1.2 Global Cholera Vaccine (Oral Route) Revenue by Type (2015-2020)
    • 4.1.3 Cholera Vaccine (Oral Route) Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Cholera Vaccine (Oral Route) Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Cholera Vaccine (Oral Route) Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Cholera Vaccine (Oral Route) Revenue Forecast by Type (2021-2026)
    • 4.2.3 Cholera Vaccine (Oral Route) Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Cholera Vaccine (Oral Route) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Cholera Vaccine (Oral Route) Market Size by Application (2015-2020)
    • 5.1.1 Global Cholera Vaccine (Oral Route) Sales by Application (2015-2020)
    • 5.1.2 Global Cholera Vaccine (Oral Route) Revenue by Application (2015-2020)
    • 5.1.3 Cholera Vaccine (Oral Route) Price by Application (2015-2020)
  • 5.2 Cholera Vaccine (Oral Route) Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Cholera Vaccine (Oral Route) Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Cholera Vaccine (Oral Route) Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Cholera Vaccine (Oral Route) Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Cholera Vaccine (Oral Route) by Country
    • 6.1.1 North America Cholera Vaccine (Oral Route) Sales by Country
    • 6.1.2 North America Cholera Vaccine (Oral Route) Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Cholera Vaccine (Oral Route) Market Facts & Figures by Type
  • 6.3 North America Cholera Vaccine (Oral Route) Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Cholera Vaccine (Oral Route) by Country
    • 7.1.1 Europe Cholera Vaccine (Oral Route) Sales by Country
    • 7.1.2 Europe Cholera Vaccine (Oral Route) Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Cholera Vaccine (Oral Route) Market Facts & Figures by Type
  • 7.3 Europe Cholera Vaccine (Oral Route) Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Cholera Vaccine (Oral Route) by Region
    • 8.1.1 Asia Pacific Cholera Vaccine (Oral Route) Sales by Region
    • 8.1.2 Asia Pacific Cholera Vaccine (Oral Route) Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Cholera Vaccine (Oral Route) Market Facts & Figures by Type
  • 8.3 Asia Pacific Cholera Vaccine (Oral Route) Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Cholera Vaccine (Oral Route) by Country
    • 9.1.1 Latin America Cholera Vaccine (Oral Route) Sales by Country
    • 9.1.2 Latin America Cholera Vaccine (Oral Route) Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Cholera Vaccine (Oral Route) Market Facts & Figures by Type
  • 9.3 Central & South America Cholera Vaccine (Oral Route) Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Cholera Vaccine (Oral Route) by Country
    • 10.1.1 Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country
    • 10.1.2 Middle East and Africa Cholera Vaccine (Oral Route) Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Cholera Vaccine (Oral Route) Market Facts & Figures by Type
  • 10.3 Middle East and Africa Cholera Vaccine (Oral Route) Market Facts & Figures by Application

11 Company Profiles

  • 11.1 PaxVax
    • 11.1.1 PaxVax Corporation Information
    • 11.1.2 PaxVax Description and Business Overview
    • 11.1.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 PaxVax Cholera Vaccine (Oral Route) Products Offered
    • 11.1.5 PaxVax Related Developments
  • 11.2 Sanofi
    • 11.2.1 Sanofi Corporation Information
    • 11.2.2 Sanofi Description and Business Overview
    • 11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Sanofi Cholera Vaccine (Oral Route) Products Offered
    • 11.2.5 Sanofi Related Developments
  • 11.3 Valneva
    • 11.3.1 Valneva Corporation Information
    • 11.3.2 Valneva Description and Business Overview
    • 11.3.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Valneva Cholera Vaccine (Oral Route) Products Offered
    • 11.3.5 Valneva Related Developments
  • 11.4 EuBiologics
    • 11.4.1 EuBiologics Corporation Information
    • 11.4.2 EuBiologics Description and Business Overview
    • 11.4.3 EuBiologics Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 EuBiologics Cholera Vaccine (Oral Route) Products Offered
    • 11.4.5 EuBiologics Related Developments
  • 11.1 PaxVax
    • 11.1.1 PaxVax Corporation Information
    • 11.1.2 PaxVax Description and Business Overview
    • 11.1.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 PaxVax Cholera Vaccine (Oral Route) Products Offered
    • 11.1.5 PaxVax Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Cholera Vaccine (Oral Route) Market Estimates and Projections by Region
    • 12.1.1 Global Cholera Vaccine (Oral Route) Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Cholera Vaccine (Oral Route) Revenue Forecast by Regions 2021-2026
  • 12.2 North America Cholera Vaccine (Oral Route) Market Size Forecast (2021-2026)
    • 12.2.1 North America: Cholera Vaccine (Oral Route) Sales Forecast (2021-2026)
    • 12.2.2 North America: Cholera Vaccine (Oral Route) Revenue Forecast (2021-2026)
    • 12.2.3 North America: Cholera Vaccine (Oral Route) Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Cholera Vaccine (Oral Route) Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Cholera Vaccine (Oral Route) Sales Forecast (2021-2026)
    • 12.3.2 Europe: Cholera Vaccine (Oral Route) Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Cholera Vaccine (Oral Route) Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Cholera Vaccine (Oral Route) Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Cholera Vaccine (Oral Route) Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Cholera Vaccine (Oral Route) Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Cholera Vaccine (Oral Route) Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Cholera Vaccine (Oral Route) Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Cholera Vaccine (Oral Route) Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Cholera Vaccine (Oral Route) Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Cholera Vaccine (Oral Route) Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Cholera Vaccine (Oral Route) Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Cholera Vaccine (Oral Route) Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Cholera Vaccine (Oral Route) Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Cholera Vaccine (Oral Route) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Cholera Vaccine (Oral Route) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Cholera Vaccine (Oral Route) Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Cholera Vaccine (Oral Route) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cholera Vaccine (Oral Route) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Cholera Vaccine (Oral Route) market is segmented into
    Shanchol
    Dukoral
    Vaxchora
    Others

    Segment by Application, the Cholera Vaccine (Oral Route) market is segmented into
    Hospital
    Research & Academic Laboratories
    Pharmaceutical & Biotechnology Companies
    Others

    Regional and Country-level Analysis
    The Cholera Vaccine (Oral Route) market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Cholera Vaccine (Oral Route) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Cholera Vaccine (Oral Route) Market Share Analysis
    Cholera Vaccine (Oral Route) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cholera Vaccine (Oral Route) business, the date to enter into the Cholera Vaccine (Oral Route) market, Cholera Vaccine (Oral Route) product introduction, recent developments, etc.

    The major vendors covered:
    PaxVax
    Sanofi
    Valneva
    EuBiologics
    ...

    Buy now